Latuda

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
NDA200603 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Latuda Is Indicated For: Latuda Is Indicated For: Treatment Of Adult And Adolescent Patients (13 To 17 Years) With Schizophrenia [See Clinical Studies ( 14.1 )] . Monotherapy Treatment Of Adult And Pediatric Patients (10 To 17 Years) With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar Depression) [See Clinical Studies ( 14.2 )] . [See Clinical Studies ( 14.2 )] Adjunctive Treatment With Lithium Or Valproate In Adult Patients With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar Depression) [See Clinical Studies ( 14.2 )] . Latuda Is An Atypical Antipsychotic Indicated For The Treatment Of: Schizophrenia In Adults And Adolescents (13 To 17 Years) ( 1 , 14.1 ) Depressive Episode Associated With Bipolar I Disorder (Bipolar Depression) In Adults And Pediatric Patients (10 To 17 Years) As Monotherapy ( 1 , 14.2 ) Depressive Episode Associated With Bipolar I Disorder (Bipolar Depression) In Adults As Adjunctive Therapy With Lithium Or Valproate ( 1 , 14.2 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lurasidone Hydrochloride LURASIDONE HYDROCHLORIDE ZINC3927822

Comments